4//SEC Filing
SULLIVAN GREGORY M 4
Accession 0001387131-21-002884
CIK 0001430306other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:47 PM ET
Size
9.6 KB
Accession
0001387131-21-002884
Insider Transaction Report
Form 4
SULLIVAN GREGORY M
Chief Medical Officer
Transactions
- Award
Stock Option
2021-02-23+750,000→ 750,000 totalExercise: $1.22From: 2022-02-23Exp: 2031-02-23→ Common Stock (750,000 underlying) - Award
Stock Option
2021-02-23+750,000→ 750,000 totalExercise: $1.53From: 2022-02-23Exp: 2031-02-23→ Common Stock (750,000 underlying) - Award
Common Stock, $0.001 par value
2021-01-07$0.51/sh+41,322$21,074→ 62,727 total
Footnotes (3)
- [F1]The shares were purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan and are not required to be filed on a Form 4.
- [F2]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F3]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
Documents
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001610106
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:47 PM ET
- Size
- 9.6 KB